Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training

Lancet

Volumn 353, Issue 9152, 1999, Pages 541-545

  Montgomery, Hugh ^a   Clarkson, Peter ^b   Barnard, Maria ^c   Bell, Jimmy ^c   Brynes, Audrey ^c   Dollery, Claire ^b   Hajnal, Joseph ^c   Hemingway, Harry ^a   Mercer, Dawn ^d   Jarman, Paul ^b   Marshall, Richard ^a   Prasad, Krishna ^e   Rayson, Mark ^f   Saeed, Nadeem ^c   Talmud, Phillipa ^a   Thomas, Louise ^c   Jubb, Mick ^g   World, Michael ^g   Humphries, Steve ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^e ST GEORGE S HOSPITAL   (United Kingdom)

^f Optimal Performance Ltd   (United Kingdom)

^g Royal Defence Medical College   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ARTICLE; BODY COMPOSITION; ENERGY BALANCE; ENZYME ACTIVITY; EXERCISE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; METABOLISM; MORPHOLOGY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SKELETAL MUSCLE; SKINFOLD THICKNESS; TRAINING;

EID: 0032994455     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)07131-1     Document Type: Article

References (44)

1. Kem DC, Brown RD. Renin - from beginning to end. N Engl J Med 1990; 323: 1136-37.
2. Dzau VJ. Circulating vs local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988; 77 (suppl 1): 14-13.
3. Jonsson JR, Game PA, Head RJ, Frewin DB. The expression and localisation of the angiotensin-converting enzyme mRNA in human adipose tissue. Blood Press 1994; 3: 72-75.
4. Dragovic T, Minhall R, Jackman HL, Wang L-X, Erdos EG. Kininase II-type enzymes: their putative role in muscle energy metabolism. Diabetes 1996; 45 (suppl 1): S34-37.
5. The Acute Infarction Rampiril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-28.
6. Danser AH, Schalekamp MA, Bax WA, et al. Angiotensin converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-88.
7. Bolla MK, Haddad L, Humphries SE, Winder AF, Day INM. A method for determination of hundreds of APOE genotypes utilising highly simplified, optimised protocols and restriction digestion analysis by microtitre array diagonal gel electrophoresis (MADGE). Clin Chem 1995; 41: 1599-604.
8. Montgomery HE, Clarkson P, Dollery CM, et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997; 96: 741-47.
9. Montgomery HE, Marshall RM, Hemingway H, et al. Human gene for physical performance. Nature 1998; 393: 221-22.
10. Gutin B, Litaker M, Islam S, et al. Body-composition measurement in 9-11-year-old children by dual-energy X-ray absorptiometry, skinfold-thickness measurements, and bioimpedance analysis. Am J Clin Nutr 1996; 63: 287-92.
11. Ghosh S, Meister D, Cowen S, Hannan WJ, Ferguson A. Body composition at the bedside. Eur J Gastro Hepat 1997; 9: 783-88.
12. Durnin JV, Womersley J. Body fat assessment from total body density and its estimate from skinfold thicknesses: measurements of 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32: 77-87.
13. SAS Institute. SAS Users Guide. Cary NC: SAS Institute, 1990.
14. Senn S. Letter to the editor. Stat Med 1991; 10: 1157-60.
15. Katsuya T, Horiuchi M, Chen YD, et al. Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. Arterioscler Thromb Vasc Biol 1995; 15: 779-82.
16. Bloom SR, Johnson RH, Park DM, Rennie MJ, Salaiman WR. Difference in the metabolic and hormonal response to exercise between racing cyclists and untrained individuals. J Physiol 1976; 258: 1-18.
17. Wasserman DH, Vranio M. Interactions between insulin, glucagon and catecholamines in the regulation of glucose production and uptake during exercise: physiology and diabetes. In: Saltin B, ed. Biochemistry of exercise VI. Champagne, Illinois: Human Kinetics, 1986: 167-79.
18. Rennie MJ, Winder WW, Holloszy O. A sparing effect of increased plasma fatty acids on muscle and liver glycogen content in the exercising rat. Biochemistry 1976; 156: 647-55.
19. McKenzie CA, Julier C, Forrester T, et al. Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative trait loci. Am J Hum Genet 1995; 57: 1426-35.
20. Messerli FH, Nowaczynski W, Honda M, et al. Effects of angiotensin II on steroid metabolism and hepatic blood flow in man. Circ Res 1977; 40: 204-07.
21. Bunneman B, Fuxe K, Ganten D. The brain renin-angiotensin system: localization and general significance. J Cardiovasc Pharmacol 1992; 19 (suppl 6): S51-62.
22. Levens NR. Local control of jejunal absorption by the renin-angiotensin system. J Cardiovasc Pharmacol 1986; 8 (suppl 10): S17-22.
23. Jones BH, Standridge MK, Taylor JW, Moustaid N. Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional contol. Am J Physiol 1997; 273: R236-42.
24. Campbell DJ, Kladis A, Duncan AM. Bradykinin peptides in kidney, blood, and other tissues of the rat. Hypertension 1993; 21: 155-65.
25. Goldman J, Pfister D, Vulmirovich R. Potentiation of insulin stimulation of hexose transport by kallikrein and bradykinin in isolated rat adipocytes. Mol Cell Endocrinol 1987; 50: 183-91.
26. Hennes MM, O'Shaughnessy IM, Kelly TM, et al. Insulin-resistant lipolysis in abdominally obese hypertensive individuals: role of the renin-angiotensin system. Hypertension 1996; 28: 120-26.
27. Rabito SF, Minshall RD, Nakamura F, Wang L-X. Bradykinin B2 receptors on skeletal muscle are coupled to inositol 1,4,5-triphosphate formation. Diabetes 1996; 45 (suppl 1): S29-33.
28. Dietze G, Wicklmayr M, Bottger I, et al. The kallikrein-kinin system and muscle metabolism: biochemical aspects. Agents Actions 1980; 10: 334-43.
29. Carretero O, Nasjletti A, Fasciolo JC. The kinin content of human blood at rest and during vasodilation. Experientia 1965; 21: 141-42.
30. Henriksen EJ, Jacob S. Effect of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 1995; 44: 267-72.
31. Jauch KW, Hartl WH, Georgieff M, et al. Low-dose bradykinin infusion reduces endogenous glucose production in surgical patients. Metabolism 1988; 37: 185-90.
32. Wicklmayr M, Dietze G, Gunther B, et al. The kallikrein-kinin system and muscle metabolism - clinical aspects. Agents Actions 1980; 10: 339-43.
33. Hespel P, Vergauwen L, Vandenberghe K, Richter EA. Significance of insulin for glucose metabolism in skeletal muscle during contractions. Diabetes 1996; 45 (suppl 1): S99-104.
34. Schieffer B, Wollert KC, Berchtold M, et al. Development and prevention of skeletal muscle structural alterations after experimental myocardial infarction. Am J Physiol 1995; 269: H1507-13.
35. Rossetti L, Stenbit AE, Chen W, et al. Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene. J Clin Invest 1997; 100: 1831-39.
36. Reisenleiter F, Kat N, Gardemann A. Control of hepatic carbohydrate metabolism and haemodynamics in perfused rat liver by arterial and portal angiotensin II. Eur J Gastroenterol Hepatol 1996; 8: 279-86.
37. Brink M, Wellen J, Delafontaine P. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J Clin Invest 1996; 97: 2509-16.
38. Townsend RR, DiPette DJ. Pressor doses of angiotensin II increase insulin-mediated glucose uptake in normotensive men. Am J Physiol 1993; 265: E362-66.
39. Laycock SK, Vogel T, Forfia PR, et al. Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ Res 1998; 82: 1263-71.
40. Wolin MS, Hintze TH, Shen W, Mohazzab H, Xie YW. Involvement of reactive oxygen species in signalling mechanisms that control tissue respiration in muscle. Biochem Soc Trans 1997; 25: 934-39.
41. Linz W, Wiemer G, Scholkens BA. Role of kinins in the pathophysiology of myocardial ischaemia: in vitro and in vivo studies. Diabetes 1996; 45 (suppl 1): S51-58.
42. Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997; 96: 526-34.
43. Anker SD, Ponikowski P, Varney S, et al. Wasting as an independent risk factor for mortality in chronic heart failure. Lancet 1997; 349: 1050-53.
44. Zhang X, Xie YW, Nasjletti A, et al. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation 1997; 95: 176-82.